[Arsenic efficient in acute promyelocytic leukemia].

Abstract

Arsenic compounds have been utilised in medicine for over 2,000 years. Recently, arsenic trioxide has been shown to induce complete remission in up to 90% of patients with acute promyelocytic leukemia (APL), including those resistant to standard therapy. Randomised studies are currently investigating the potential clinical utility of this drug in APL. In… (More)

Topics

  • Presentations referencing similar topics